Location: Italy, Lombardy, Milan
Employees: 11-50
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 19
| Date | Name | Website | Total Raised | Location |
| 06.10.2025 | NanoPhoria... | nanophoria.com | $115.98M | Italy |
| 29.11.2023 | Nouscom AG | nouscom.com | $135.77M | Switzerlan... |
| 26.10.2023 | Approxima | approximamedical.com | - | Italy, Lom... |
| 02.08.2023 | Allotex | allotex.com | - | United Sta... |
| 02.08.2023 | EBAMed | eba-med.com | $18.62M | Switzerlan... |
| 01.05.2023 | Complement... | complementtx.com | $84.66M | United Kin... |
| 11.08.2022 | SamanTree ... | samantree.com | $50.43M | United Sta... |
| 11.08.2022 | Vivasure M... | vivasuremedical.com | $73.84M | Ireland, G... |
| 10.04.2022 | Neuromod D... | neuromoddevices.com | $71.46M | Ireland, D... |
| 21.12.2018 | DIADEM DX | diademdx.com | $12.75M | Italy, Lom... |
Show more
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Michela | Barcella | Network an... | linkedin.c... | - | i*********... |
News 37
| Date | Title | Description |
| 27.09.2021 | PANAKÈS PARTNERS APPOINTS DR. ROB WOODMAN AS PARTNER TO LEAD BIOTECH INVESTMENT | PANAKÈS PARTNERS APPOINTS DR. ROB WOODMAN AS PARTNER TO LEAD BIOTECH INVESTMENT DR. ROB WOODMAN BRINGS 15 YEARS OF EXPERIENCE IN LIFE SCIENCE INVESTING AND A TRACK RECORD OF SUCCESS IN BOTH INSTITUTIONAL AND CORPORATE VENTURE CAPITAL • Pana... |
| 28.07.2021 | Panakes Partners Announces the hiring of Dr. Marco Sardina as Scientific Partner and Dr. Andrea Ballerini as Associate | Panakes Partners SGR, a leading Venture Capital investor creating and building the next generation of innovative European Life Science companies, announced today that Dr. Marco Sardina has joined the team as Scientific Partner and Dr. Andre... |
| 20.07.2021 | PANAKÈS PARTNERS ANNOUNCES THE FIRST CLOSING OF ITS NEW “PURPLE” GLOBAL BIOTECH/ MEDTECH | PANAKÈS PARTNERS ANNOUNCES THE FIRST CLOSING OF ITS NEW “PURPLE” GLOBAL BIOTECH/ MEDTECH FUND AT €150 MILLION ($180 MILLION) • Panakès will use the successful closing of its second Fund to extend its investment activity to biotech, while ma... |
| 01.07.2021 | Salvia BioElectronics B.V. ("Salvia"), a neurostimulation platform company targeting chronic migraine, announces today the appointment | Salvia BioElectronics B.V. ("Salvia"), a neurostimulation platform company targeting chronic migraine, announces today the appointment of Dr Alan Levy as Chairman of the Board of Directors. Dr Levy has 40 years of senior operation... |
| 09.06.2021 | CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces preclinical results | CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces preclinical results in the testing of the combination of SonoCloud® technology with immunotherapies. ... |
| 04.06.2021 | Endostart,startup toscana che ha sviluppato una piattaforma endoscopica che mira alle colonscopie incomplete, già certificata ISO13485 | Endostart, startup toscana che ha sviluppato una piattaforma endoscopica che mira alle colonscopie incomplete, già certificata ISO13485, ha annunciato di aver chiuso, insieme a nuovi e già presenti investitori, un aumento di capitale di €8.... |
| 13.05.2021 | Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD) | Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today announced new data showing that its AlzoSure® prognostic biomarker test can accurately predict progression to Alzheimer'... |
| 06.04.2021 | Vivasure Medical®, a company pioneering fully absorbable solutions for large hole percutaneous vessel closure, today announced Andrew Glass has assumed the role of chief executive | Vivasure Medical®, a company pioneering fully absorbable solutions for large hole percutaneous vessel closure, today announced Andrew Glass has assumed the role of chief executive officer. Founder and former CEO Ger Brett will transition to... |
| 12.03.2021 | Panakès Partners sgr, società di venture capital specializzata in investimenti in aziende innovative nel settore delle scienze della vita, ha nominato partner Barbara Castellano | Panakès Partners sgr, società di venture capital specializzata in investimenti in aziende innovative nel settore delle scienze della vita, ha nominato partner Barbara Castellano e assunto con la carica di direttore finanziario Lorenzo Giord... |
| 12.02.2021 | Aileens Pharma, società di biotecnologia impegnata nella ricerca clinica, attiva nello sviluppo di trattamenti per le malattie della pelle | Aileens Pharma, società di biotecnologia impegnata nella ricerca clinica, attiva nello sviluppo di trattamenti per le malattie della pelle che colpiscono il microbioma cutaneo, ha annunciato la nomina di Mathieu Simon a presidente del Consi... |
Show more
Mentions in press and media 23
| Date | Title | Description |
| 13.10.2025 | NanoPhoria Bioscience: €83.5 Million Series A Secured For Advancing Heart Failure Therapy | NanoPhoria Bioscience, a biotech company based in Milan, announced the first close of its €83.5 million Series A financing round. This round was led by XGEN Venture, Sofinnova Partners, and CDP Venture Capital, with additional investments f... |
| 06.10.2025 | NanoPhoria Bioscience Raises €83.5M in Series A Funding | NanoPhoria Biosciences, a Milan, Italy-based biotech company developing a nano-in-micro and lung-to-heart delivery platform, raised €83.5M in Series A funding. The round was led by XGEN Venture, Sofinnova Partners, and CDP Venture Capital, ... |
| 06.10.2025 | NanoPhoria closes €83.5 million Series A for its heart failure candidate – one of Italy’s largest 2025 BioTech rounds | Milan-based NanoPhoria Bioscience today announced the successful first close of its €83.5 million Series A financing round – the largest ever Series A round in Italian BioTech history – for its lung-to-heart drug delivery platform. The roun... |
| 24.01.2025 | EBAMed completes Series A with EUR 1.6M investment | The new funds were raised from CDP Venture Capital as part of the PNRR (Piano Nazionale di Ripresa e Resilienza) and the Next Generation EU initiative. This significant new milestone brings the startup led by CEO Marina Izzo to the maximum... |
| 09.10.2024 | Lymphatica Medical raises €17.9 million in series B Funding | First of its kind, LymphoDrain is easy to implant subcutaneously through a minimally invasive technique and it’s intended to provide unprecedent benefits to patients by locally and actively replacing the lymphatic vessels draining function... |
| 12.09.2024 | CorFlow Therapeutics Secures €44 Million to Revolutionize Heart Attack Treatment | CorFlow Therapeutics is on a mission. The Swiss company has just raised €44 million in a Series B funding round, co-led by Broadview Ventures and Panakes Partners. This influx of capital is not just a financial boost; it’s a lifeline for pa... |
| 12.09.2024 | CorFlow Therapeutics raises €44 million in Series B round | Headquarted in Baar (Zug), CorFlow’s Controlled Flow Infusion (CoFI) system is being developed to provide timely, accurate and consistent detection of Microvascular Obstruction (MVO) while patients are still in the catheter laboratory (cat... |
| 12.09.2024 | CorFlow Therapeutics raises €44 million in Series B round | Co-led by Broadview Ventures and Panakes Partners, CoFlow’s series B round received strong continued support from 415 Capital, its initial VC investor and largest shareholder. Merieux Equity Partners, Laerdal Million Lives Fund, Wellington... |
| 17.07.2024 | SamanTree Medical makes strategic changes after $14M round | From biopsy taking to surgical diagnosis, tissue assessment is a key component to efficient and straightforward cancer treatment. However, obtaining high-resolution results promptly remains a major challenge. SamanTree’s Histolog Scanner i... |
| 14.11.2023 | Nouscom raises CHF65 million in oversubscribed Series C financing round |
Show more